Boston Partners
TMO icon

Boston Partners’s Thermo Fisher Scientific TMO Stock Holding History

Boston Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43M Buy
10,819
+3,306
+44% +$1.59M ﹤0.01% 504
2026
Q1 		$3.69M Buy
7,513
+6,993
+1,345% +$3.8M ﹤0.01% 518
2025
Q4 		$301K Buy
+520
New +$294K ﹤0.01% 726
2025
Q1 		– Sell
-436
Closed -$227K – 767
2024
Q4 		$227K Sell
436
-33
-7% -$18.1K ﹤0.01% 700
2024
Q3 		$290K Sell
469
-3
-0.6% -$1.78K ﹤0.01% 695
2024
Q2 		$261K Sell
472
-334
-41% -$191K ﹤0.01% 689
2024
Q1 		$468K Sell
806
-70
-8% -$39.3K ﹤0.01% 703
2023
Q4 		$465K Sell
876
-948
-52% -$459K ﹤0.01% 618
2023
Q3 		$923K Hold
1,824
– – ﹤0.01% 557
2023
Q2 		$952K Sell
1,824
-853
-32% -$460K ﹤0.01% 548
2023
Q1 		$1.54M Sell
2,677
-6,353
-70% -$3.58M ﹤0.01% 489
2022
Q4 		$4.97M Sell
9,030
-2,447
-21% -$1.3M 0.01% 378
2022
Q3 		$5.82M Sell
11,477
-4,254
-27% -$2.38M 0.01% 382
2022
Q2 		$8.55M Buy
15,731
+2,653
+20% +$1.46M 0.01% 365
2022
Q1 		$7.72M Buy
13,078
+2,669
+26% +$1.53M 0.01% 377
2021
Q4 		$6.95M Sell
10,409
-2,500
-19% -$1.56M 0.01% 375
2021
Q3 		$7.38M Sell
12,909
-5,782
-31% -$3.17M 0.01% 374
2021
Q2 		$9.43M Buy
+18,691
New +$8.82M 0.01% 366
2014
Q1 		– Sell
-56,120
Closed -$6.25M – 746
2013
Q4 		$6.25M Hold
56,120
– – 0.01% 469
2013
Q3 		$5.17M Hold
56,120
– – 0.01% 485
2013
Q2 		$4.75M Buy
+56,120
New +$4.67M 0.01% 484

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Boston Partners's TMO Position: Q2 2026 in Review

Boston Partners increased its Thermo Fisher Scientific (TMO) stake by 44% in Q2 2026, buying an estimated $1.59M and bringing the position to 10,819 shares worth $5.43M. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Boston Partners first reported a position in TMO in Q2 2013 and has held it in 21 quarters since. The position peaked at $9.43M in Q2 2021. 2,215 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Boston Partners held 10,819 shares of Thermo Fisher Scientific worth $5.43M as of Q2 2026.
  • Boston Partners bought 3,306 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.59M.
  • Thermo Fisher Scientific made up ﹤0.01% of Boston Partners's portfolio in Q2 2026, its #504 holding.
  • Boston Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 21 quarters since.
  • Boston Partners's Thermo Fisher Scientific position peaked at $9.43M in Q2 2021.
  • 2,215 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.